From Name:
From Email:
To Name:
To Email:

Optional Message:

Putting More Value Into Biopharmaceutical Value Assessments

from 01/03/18, Health Affairs

Calls for prescription drug pricing transparency currently echo through state legislatures. Vermont, Maryland, and California have passed legislation requiring various aspects of prescription drug pricing to be made public. Numerous other legislative bodies are considering related efforts. Supporters of these efforts argue that providing more transparency on prescription drug prices will encourage manufacturers to set prices that can be better justified to the public. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063